Atlas Trials

Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder

Clinical trial NCT00633802 · UNKNOWN

Trial details

NCT number
NCT00633802
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Borderlone Personality Disorder
Start date
2004-04-01
Primary completion
2009-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.